Ocular Surface Changes in Primary Open Angle Glaucoma Patients Treated With Topical Antihypertensive Drugs

被引:2
|
作者
Castro, Catarina [1 ,4 ]
Marta, Ana [1 ,2 ]
Marques, Joao H. [1 ]
Ferreira, Andre [1 ,3 ]
Jose, Diana [1 ]
Sousa, Paulo [1 ]
Neves, Isabel [1 ]
Meneres, Maria Joao [1 ,2 ]
Barbosa, Irene [1 ,2 ]
机构
[1] Univ Porto, Ctr Hosp Univ St Antonio, Dept Ophthalmol, Porto, Portugal
[2] Univ Porto, Inst Biomed Sci Abel Salazar, Dept Ophthalmol, Porto, Portugal
[3] Univ Porto, Dept Biomed, Unit Anat, Fac Med, Porto, Portugal
[4] Ctr Hosp Univ Porto, Dept Ophthalmol, P-4099001 Porto, Portugal
关键词
glaucoma; ocular surface; dry eye disease; QUALITY-OF-LIFE; DRY EYE SYNDROME; INTRAOCULAR-PRESSURE; DISEASE;
D O I
10.1097/IJG.0000000000002272
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Precis: In this study, patients with glaucoma undergoing topical antihypertensive (TAH) drugs had changes in the ocular surface and more dry eye symptoms than controls. Clinicians should recognize the influence of TAH drops on exacerbating ocular surface disease.Purpose: The purpose of this study was to evaluate the ocular surface of eyes with glaucoma treated with TAH drugs.Methods: Cross-sectional study that included eyes undergoing TAH drugs due to primary open angle glaucoma and controls. The parameters evaluated were: the basal tear flow (basic secretion test); the tear film osmolarity (TearLab); and the noninvasive break-up time, blink score, lipid layer thickness, tear meniscus height, and loss area of the meibomian glands, measured with the IDRA Ocular Surface Analyser. Presence of symptoms [Ocular Surface Disease Index (OSDI)], dry eye disease (DED, TFOS DEWS II criteria), and corneal fluorescein staining were assessed.Results: We included 154 eyes (154 patients), 77 undergoing TAH drugs for glaucoma (group 1) and 77 of controls (group 2). The tear film osmolarity (P=0.003) and the loss area of the meibomian glands (P=0.004) were higher in group 1. The noninvasive break-up time (P=0.005), lipid layer thickness (P=0.006), and tear meniscus height (P=0.001) were lower in group 1. The global OSDI score (P<0.001), the proportion of eyes with severe disease (P=0.002), according to the OSDI, and with DED (P<0.001), according to the TFOS DEWS II criteria, were higher in group 1. The proportion of patients with corneal fluorescein staining was higher in group 1 (P<0.001). There were no significant differences in eyes taking TAH drugs with and without preservatives (P>0.127).Conclusions: DED, in patients with glaucoma, is a multifactorial disease, with a strong contribution from TAH drugs. These eyes had changes in almost every measured parameter, translating into the presence of more dry eye symptoms and corneal damage when compared with controls.
引用
收藏
页码:E113 / E120
页数:8
相关论文
共 50 条
  • [1] ELECTROOCULOGRAM CHANGES IN PATIENTS WITH OCULAR HYPERTENSION AND PRIMARY OPEN-ANGLE GLAUCOMA
    MEHAFFEY, L
    HOLOPIGIAN, K
    SEIPLE, W
    DOCUMENTA OPHTHALMOLOGICA, 1993, 83 (02) : 103 - 110
  • [2] Increased corneal hysteresis in treated Ocular Hypertension and Primary Open Angle Glaucoma
    Molinari, Joseph F.
    Newcomb, Robert D.
    Patterson, Leslie
    Rivera, Angel L.
    OPTOMETRY-JOURNAL OF THE AMERICAN OPTOMETRIC ASSOCIATION, 2012, 83 (06) : 259 - 263
  • [3] The influence of glaucoma medications on ocular surface disease in primary open-angle glaucoma patients with and without conjunctivochalasis
    Kocabeyoglu, Sibel
    Mocan, Mehmet C.
    Irkec, Murat
    ACTA OPHTHALMOLOGICA, 2014, 92 (07) : e592 - e593
  • [4] Ocular surface changes in primary open-angle glaucoma on anti-glaucoma medications versus treatment-naïve patients
    Srivastava, Krati
    Bhatnagar, Kavita R.
    Shakrawal, Jyoti
    Tandon, Manjari
    Jaisingh, Kirti
    Pandey, Latika
    Roy, Falguni
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2024, 72 (03) : 374 - 380
  • [5] Effects of the time of antihypertensive drugs administration on the stage of primary open-angle glaucoma in patients with arterial hypertension
    Krasinska, Beata
    Karolczak-Kulesza, Malgorzata
    Krasinski, Zbigniew
    Pawlaczyk-Gabriel, Katarzyna
    Lopatka, Pawel
    Gluszek, Jerzy
    Tykarski, Andrzej
    BLOOD PRESSURE, 2012, 21 (04) : 240 - 248
  • [6] Ocular hypotensive effect of ketanserin in patients with primary open angle glaucoma
    Mastropasqua, L
    Costagliola, C
    Ciancaglini, M
    Carpineto, P
    Gallenga, PE
    ACTA OPHTHALMOLOGICA SCANDINAVICA, 1997, 75 : 24 - 25
  • [7] Ocular pulse amplitude in primary open angle glaucoma patients on brimonidine
    Kazakos, DC
    Schmidt, KG
    Bernd, AS
    Böhm, AG
    Pillunat, LE
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U182 - U182
  • [8] Doppler Evaluation of Ocular Vessels in Patients with Primary Open Angle Glaucoma
    Suprasanna, K.
    Shetty, Chandrakant M.
    Charudutt, S.
    Kadavigere, Rajagopal
    JOURNAL OF CLINICAL ULTRASOUND, 2014, 42 (08) : 486 - 491
  • [9] Longitudinal changes in function and structure in primary open angle glaucoma and ocular hypertension
    Kim, LS
    Wild, JM
    Cunliffe, IA
    Hancock, SA
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U9 - U9
  • [10] Effect of a Topical Combination of Latanoprost and Pranoprofen on Intraocular Pressure and the Ocular Surface in Open-Angle Glaucoma Patients
    Zhu, Simin
    Wang, Dabo
    Han, Jing
    JOURNAL OF OPHTHALMOLOGY, 2018, 2018